Group
COVID-19 [11]
Full Professor
Permanent Researcher
Marie-Anne Rameix-Welti
Molecular mechanisms of multiplication of Pneumoviruses M3P
I am a virologist with a special interest in the study of the fundamental mechanisms of virus multiplication and their links to human health. I have a dual medical and scientific background that allows […]
PhD Student
Alexandre Elabbadi
Epidemiology and modelling of bacterial escape to antimicrobials
Alexandre Elabbadi is a pulmonary specialist physician. His research interests are mainly focused on lower respiratory infections, especially in critical care patients. He is since November 2022 at the Pasteur Institute as PhD student. […]
Project
Pro-actively addressing the challenges for an effective uptake of COVID-19 vaccination in Belgium: a transdisciplinary approach (Transvaxx project)
Tamara Giles-Vernick • Léonard Heyerdahl
Research Engineer
Laura Garcia
Infectious Disease Epidemiology and Analytics
I joined the Infectious Diseases Epidemiology and Analytics G5 Unit in 2021, first as a student during my Master 2 internship, and now as a research engineer. I worked on the development of multiplex […]
Laboratory
Institut Pasteur-TheraVectys Joint Laboratory
Pierre Charneau
Non-permanent Researcher
Stéphane PELLEAU
Infectious Disease Epidemiology and Analytics
My research interests focus on the interaction between malaria parasites and its human host through the analysis of biological mechanisms such as drug resistance or immunity that have an impact on disease epidemiology and […]
Assistant Professor
Guilherme Dias de Melo
Trypanosomatids Infectious Processes
Guilherme Dias de Melo is veterinarian. He obtained his degree in Veterinary Medicine (december 2010), his MD in Veterinary Sciences (june 2012) and his PhD in Veterinary Sciences (june 2015) at the Sao Paulo […]
Research Engineer
Maryline Bourgine
Institut Pasteur-TheraVectys Joint Laboratory
Laboratory
Humoral Immunology
Hugo Mouquet
Permanent Researcher
Timothée Bruel
Antiviral Activities of Antibodies
My work focuses on the antiviral activities of antibodies against HIV-1 and SARS-CoV-2. Despite the success of anti-retroviral therapy (ART) to treat HIV-1-infected individuals, the persistence of a viral reservoir remains an obstacle to […]